Bahasa Indonesia
English
中文 (香港)
Morula IVF Indonesia is the first clinic in Indonesia to offer Pre-implantation Genetic Testing for Aneuploidy (PGT-A) technology. PGT-A is the most advanced technology for screening chromosomes in embryos. It identifies the number of chromosomes in an embryo before it is transferred to the uterus. PGT-A is expected to optimize the success rate of IVF pregnancies and reduce the risk of miscarriage or birth defects.
PGT-A is performed by taking a few cells from the trophoblast (the future placenta) on day 5, as many as (5-10) trophoblast cells of the embryo. The cells are then analyzed to evaluate the number of chromosomes. If a chromosomal abnormality is detected, the embryo is not transferred to the patient’s uterus. This technology allows couples to choose healthy embryos that have a greater chance of implanting in the uterus and developing into a healthy baby. In addition, it can be used to detect abnormalities in the XX or XY chromosomes of the embryo. PGT-A is highly recommended for patients over the age of 37.